PT91852A - Processo para a preparacao de produtos contendo psyllium - Google Patents

Processo para a preparacao de produtos contendo psyllium

Info

Publication number
PT91852A
PT91852A PT91852A PT9185289A PT91852A PT 91852 A PT91852 A PT 91852A PT 91852 A PT91852 A PT 91852A PT 9185289 A PT9185289 A PT 9185289A PT 91852 A PT91852 A PT 91852A
Authority
PT
Portugal
Prior art keywords
mesh
preparation
products containing
psyllium
containing psyllium
Prior art date
Application number
PT91852A
Other languages
English (en)
Other versions
PT91852B (pt
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PT91852A publication Critical patent/PT91852A/pt
Publication of PT91852B publication Critical patent/PT91852B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Seeds, Soups, And Other Foods (AREA)
PT91852A 1988-10-03 1989-09-29 Processo para a preparacao de produtos contendo psyllium PT91852B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25284888A 1988-10-03 1988-10-03

Publications (2)

Publication Number Publication Date
PT91852A true PT91852A (pt) 1990-04-30
PT91852B PT91852B (pt) 1995-08-09

Family

ID=22957807

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91852A PT91852B (pt) 1988-10-03 1989-09-29 Processo para a preparacao de produtos contendo psyllium

Country Status (18)

Country Link
EP (1) EP0362926B1 (pt)
JP (1) JP3338047B2 (pt)
KR (1) KR0157298B1 (pt)
AT (1) ATE89736T1 (pt)
AU (1) AU636304B2 (pt)
BR (1) BR8905020A (pt)
CA (1) CA1331535C (pt)
DE (1) DE68906746T2 (pt)
DK (1) DK175227B1 (pt)
ES (1) ES2055014T3 (pt)
FI (1) FI100304B (pt)
GR (1) GR3007981T3 (pt)
HK (1) HK99296A (pt)
IE (1) IE62926B1 (pt)
MY (1) MY110014A (pt)
NZ (1) NZ230859A (pt)
PH (1) PH27246A (pt)
PT (1) PT91852B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI932843L (fi) * 1990-12-20 1993-06-18 Procter & Gamble Psyllium- och kolestyraminkompositioner med foerbaettrad smaklighet
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
US5085785A (en) * 1991-03-28 1992-02-04 The Procter & Gamble Company Process for purifying psyllium husk using liquid fluorinated hydrocarbons with different densities as separation means
US5234687A (en) * 1991-10-21 1993-08-10 The Procter & Gamble Company Method of making an unflavored psyllium drink mix
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
DK0630192T3 (da) * 1992-03-11 1996-12-09 Procter & Gamble Psyllium-drikkeblandingsprodukter indeholdende granuleret base
WO1993017590A1 (en) * 1992-03-11 1993-09-16 The Procter & Gamble Company Unflavored psyllium drink mix compositions
CZ218194A3 (en) * 1992-03-11 1995-01-18 Procter & Gamble Plantain drinking mixtures with reduced size of particles
WO1993018756A1 (en) * 1992-03-20 1993-09-30 The Procter & Gamble Company Anion exchange resin compositions
US5234916A (en) * 1992-06-12 1993-08-10 The Proctor & Gamble Company Psyllium drink mix compositions
US5232698A (en) * 1992-06-12 1993-08-03 The Proctor & Gamble Company Psyllium drink mix compositions
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US5651988A (en) * 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
US5766638A (en) * 1995-12-08 1998-06-16 The Dow Chemical Company Hydroxypropyl methocellulose ether compositions for reduction of serum lipid levels
KR100473531B1 (ko) * 2002-01-04 2005-03-09 씨제이 주식회사 변방 소풍순기원 생약 복합제 추출물을 함유하는 당뇨병예방 및 치료를 위한 조성물
KR100473530B1 (ko) * 2002-01-04 2005-03-09 씨제이 주식회사 소풍순기원 생약 복합제 추출물을 함유하는 당뇨병 예방및 치료를 위한 조성물
KR100839185B1 (ko) * 2007-04-09 2008-06-17 고려대학교 산학협력단 플랜타마조사이드를 유효성분으로 함유하는 당뇨 및당뇨합병증 예방/치료용 조성물
WO2021192360A1 (ja) * 2020-03-25 2021-09-30 日清食品ホールディングス株式会社 サイリウム種皮造粒物及びその製造方法、並びにサイリウム種皮造粒物を含む粉末飲料
WO2021192663A1 (ja) * 2020-03-25 2021-09-30 日清食品ホールディングス株式会社 サイリウム種皮造粒物及びその製造方法、並びにサイリウム種皮造粒物を含む粉末飲料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148114A (en) * 1959-11-20 1964-09-08 American Cyanamid Co Method of reducing cholesterol levels
US4737364A (en) * 1986-02-06 1988-04-12 Kalogris Theodore P Nutritional dry food concentrate
US4766004A (en) * 1986-12-19 1988-08-23 Warner-Lambert Company Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition

Also Published As

Publication number Publication date
KR0157298B1 (ko) 1998-11-16
GR3007981T3 (pt) 1993-08-31
MY110014A (en) 1997-11-29
HK99296A (en) 1996-06-14
DK175227B1 (da) 2004-07-12
BR8905020A (pt) 1990-05-08
AU636304B2 (en) 1993-04-29
DE68906746T2 (de) 1993-10-28
ATE89736T1 (de) 1993-06-15
DK486189D0 (da) 1989-10-03
IE62926B1 (en) 1995-03-08
AU4245289A (en) 1990-04-05
FI894673L (fi) 1990-04-04
CA1331535C (en) 1994-08-23
JPH02200167A (ja) 1990-08-08
EP0362926B1 (en) 1993-05-26
ES2055014T3 (es) 1994-08-16
PT91852B (pt) 1995-08-09
DK486189A (da) 1990-04-04
NZ230859A (en) 1991-04-26
KR900005990A (ko) 1990-05-07
DE68906746D1 (de) 1993-07-01
EP0362926A1 (en) 1990-04-11
JP3338047B2 (ja) 2002-10-28
FI100304B (fi) 1997-11-14
PH27246A (en) 1993-05-04
FI894673A0 (fi) 1989-10-03
IE893161L (en) 1990-04-03

Similar Documents

Publication Publication Date Title
PT91852A (pt) Processo para a preparacao de produtos contendo psyllium
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
NZ503248A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide
HUT53362A (en) Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
IL94068A0 (en) ((substituted naphthalenyl)-alkyl)-3h-1,2,3,5-oxathiadiazole 2-oxides,their preparation and pharmaceutical compositions containing them
CA2152615A1 (en) Atovaquone pharmaceutical compositions
IL84041A0 (en) Retinoids,their manufacture and pharmaceutical compositions containing them
IL90864A0 (en) Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them
IL93914A0 (en) 4(3h)-pteridinones,their preparation and pharmaceutical compositions containing them
IL84832A0 (en) 6-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones,their preparation and pharmaceutical compositions containing them
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
HUT50844A (en) Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient
HUT59917A (en) Process for producing sulfonamide derivatives and pharmaceutical compositions containing them as active component
HUT43829A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
IL105391A0 (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
HUT48613A (en) Process for producing carbamoyloxylabdane derivatives, their intermediaries and pharmaceutical compositions comprising such compounds as active ingredient
IL93719A0 (en) (5(6)(benzisoxa-benzisothia-or indazol-3-yl)-1h-benzimidazol-2-yl)carbamates,their preparation and pharmaceutical compositions containing them
HUT53591A (en) Process for producing polyhydroxy-benzayloxy-propanolamines and pharmaceutical compositions containing them as active component
HU895896D0 (en) Process for producing 1-amino-alkyl-3-oxy-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-one derivatives and pharmaceutical compositions containing them as active components
IL84366A0 (en) 2,6-diamino-3-halogenbenzylpyridines,their manufacture and pharmaceutical compositions containing them
AU641411B2 (en) Nitrofurantoin crystals
HUT49112A (en) Process for producing new 1-aryloxy-3-amino-2-propanols and pharmaceutical compositions comprising such active ingredient
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950403

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20021031